A small proportion (up to 1:1,000,000 in prevalence) of FH is homozygous in which both alleles (mainly LDLR) have the same mutation, therefore exhibits more severe lipid and clinical phenotypes secondary to severe LDLR functional loss [9, 14]. The gene discussed is LDLR; the disease is familial hyperaldosteronism.